Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 36c ; Offers Guidance

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of $0.14, $0.36 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $84.1 million versus the consensus estimate of $81.43 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2025 EPS of ~$0.30, versus the consensus of ($0.35). Fulgent Genetics, Inc. sees FY2025 revenue of ~$325 million, versus the consensus of $320.1 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• EyePoint Inc. (EYPT) PT Lowered to $48 at Laidlaw
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'